How to Buy Iovance Biotherapeutics Stock
Iovance Biotherapeutics Inc
Iovance Biotherapeutics, Inc. , a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells.
Iovance Biotherapeutics stock last closed at $9.99, down 4.49% from the previous day, and has increased 151.01% in one year. It has overperformed other stocks in the Biotechnology industry by 1.63 percentage points. Iovance Biotherapeutics stock is currently +211.21% from its 52-week low of $3.21, and -45.5% from its 52-week high of $18.33.
There are currently 303.51M IOVA shares outstanding. The market cap of IOVA is $3.03B. In the past 24 hours, 4.02M IOVA shares were traded.
How to Buy Iovance Biotherapeutics Stock
Not sure how to invest in Iovance Biotherapeutics stock? Here's how.
- Figure out where to buy Iovance Biotherapeutics stock: You need to choose an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Iovance Biotherapeutics stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Select your method of payment and add your details.
- Evaluate Iovance Biotherapeutics stock: The Iovance Biotherapeutics ticker symbol is IOVA. Is Iovance Biotherapeutics stock a good investment? Should you buy shares of IOVA? How do IOVA's underlying business fundamentals look? Do top analysts think Iovance Biotherapeutics is a good buy? Why has IOVA's stock price moved recently? (Hint: Our stock research tools can help you evaluate if IOVA is a good stock to buy).
- Place your IOVA purchase: Decide if you will purchase IOVA shares at the current market price or use a limit order to purchase IOVA stock at a given price.
- Get key alerts regarding your IOVA position: Create a watchlist to the latest updates on your position in Iovance Biotherapeutics shares.
Step 1: Figure out where to buy Iovance Biotherapeutics stock
You need a brokerage account in order to access the NASDAQ market and buy IOVA shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Tech to Utilities, New York to Hong Kong — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro today.
Open eToro AccountStep 2: Open a brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal info so you are able to buy IOVA stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open a new brokerage account.
- Submit your information by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you've finished signing up on the stocks app, you need to deposit funds:
Watch the video below if you need help transferring funds into your brokerage account.
Step 4: Evaluate Iovance Biotherapeutics stock
After you have selected the best place to buy Iovance Biotherapeutics stock, it's crucial to evaluate their stock prior to buying, so you can understand the risk and upside.
Iovance Biotherapeutics Metrics
IOVA Overview
WallStreetZen was designed to help average investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on IOVA's stock page.
What is the fair value of IOVA stock?
Analysts use many financial metrics, analyses, models, and charts to gauge IOVA's true value.
Using relative valuations metrics:
- IOVA may be undervalued based on its P/B ratio of 3.95x, relative to Biotechnology industry P/B ratio of 5.95x
You can access additional valuation analysis on IOVA's stock here.
IOVA Financial Health Overview
Passed Health Checks:
- IOVA has cash burn of 400480000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the IOVA balance sheet.
- IOVA has a low debt to equity ratio of 0.26.
- There are more short-term assets than short-term liabilities on the IOVA balance sheet.
Failed Health Checks:
- IOVA has $418.97M in cash and short term investments. This is not enough to cover its annual cash burn of $400.48M.
- Total IOVA debt is higher than 5 years ago, relative to shareholder equity.
- IOVA profit margin has gone up by 1,746.38 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy Iovance Biotherapeutics stock, according to analysts?
Out of 3 Equities analysts who research IOVA, the consensus analyst rating on IOVA is a Buy
Please note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Iovance Biotherapeutics stock forecast page.
IOVA Technical Indicators
IOVA Growth Metrics
Last year, IOVA revenue was $32.77M. Over the last 1 years, IOVA's revenue has grown by 13,669.75% per year. This was faster than the Biotechnology industry average of 59.82%.
Dive into IOVA's earnings and revenue performance here.
Who is buying/selling IOVA?
Over the last year, executives and large shareholders at IOVA have bought more shares than they have sold.
Jeanmarc Bellemin, Chief Financial Officer of IOVA, was the latest IOVA insider to sell. They sold $129,017.35 worth of IOVA shares on Sep 3, 2024.
Get more info about who owns IOVA shares here.
Does IOVA stock generate passive income?
No, Iovance Biotherapeutics doesn't provide an income stream by paying out dividends.
What do other traders have to say about IOVA?
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Place your IOVA purchase
There are two main order types:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly sufficient. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a specific price, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you want more help with investing in stocks on eToro, click the helpful video below:
Step 6: Get key alerts regarding your IOVA position
Now that you own some IOVA shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to track your IOVA stock.
IOVA Feed
How to Buy Stock in Iovance Biotherapeutics
To summarize, here are the 6 steps to buy Iovance Biotherapeutics stock:
- Figure out where to buy Iovance Biotherapeutics stock
- Open a brokerage account
- Deposit funds into your investment account
- Evaluate Iovance Biotherapeutics stock
- Place your IOVA purchase
- Get key alerts regarding your IOVA position
If you require a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to monitor your new investment in Iovance Biotherapeutics, click below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.